Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitusJooyeon Hwang, Bong‐Jo Kim, Nak-Hyun Choi et al.|Scientific Reports|2018Cited by 30
Differential DNA methylation of MSI2 and its correlation with diabetic traitsJae‐Pil Jeon, Suman Lee, In-Uk Koh et al.|PLoS ONE|2017Cited by 27